The Product
A breath test for cancer. Simple as that.
The Exhale Science platform combines a proprietary breath collection device, high-sensitivity VOC analysis, and AI-powered diagnostics to deliver clinical-grade cancer screening from a single exhaled breath sample.
Platform Overview
Three components. One seamless diagnostic workflow.
The Exhale Science platform is designed for integration into clinical settings — from primary care to specialist oncology practices. Every component is engineered for precision, reproducibility, and ease of use.
Breath Collection Device
A compact, non-invasive device that captures a standardized exhaled breath sample in under two minutes. No patient preparation required. No needles, no contrast agents, no radiation.
VOC Analysis System
High-sensitivity analytical instrumentation identifies and quantifies volatile organic compounds in the breath sample with parts-per-billion precision — isolating the molecular fingerprints of cancer metabolism.
AI Diagnostic Platform
Our proprietary machine learning models classify the VOC profile against validated cancer biomarker signatures, generating a structured diagnostic report for clinical review.
The Device
Designed for the clinic. Built for the patient.
Non-invasive collection
Patient exhales into the device. No blood draw, no biopsy, no preparation protocol.
Under 2 minutes
Sample collection is complete in under two minutes — faster than a standard blood draw.
Clinic-ready form factor
Compact desktop footprint designed for seamless integration into existing clinical workflows.
Tamper-evident sample integrity
Proprietary sample preservation technology maintains VOC integrity from collection through analysis.
Single-use collection cartridge
Disposable, sterile collection cartridges eliminate cross-contamination risk and simplify workflow.
EHR-compatible reporting
Diagnostic reports are formatted for direct integration with major electronic health record systems.
Exhale Science Device
Breath collection platform
Clinical Workflow
From patient to report in one clinical visit.
Patient Arrives
No fasting, no preparation, no pre-procedure protocol. The patient arrives and is ready to test.
Breath Sample Collected
The clinician places a sterile collection cartridge in the device. The patient exhales normally. Collection is complete in under two minutes.
Sample Analyzed
The cartridge is processed by our VOC analysis system, which identifies and quantifies the full breath VOC profile with parts-per-billion sensitivity.
AI Interpretation
Our diagnostic AI classifies the VOC profile against validated cancer biomarker signatures, flagging findings and generating a structured report.
Report Delivered
A clinical-grade diagnostic report is delivered to the ordering clinician — within the same visit — with findings, confidence levels, and recommended next steps.
Detection Targets
Designed for multi-cancer detection.
Our VOC biomarker panel is designed to detect molecular signatures associated with multiple cancer types from a single breath sample. Current development targets include:
Cancer type coverage is subject to ongoing clinical validation. Current targets reflect the published VOC biomarker literature and our proprietary research program.
For Clinicians
Built for clinical integration.
Adjunct to existing screening
Designed to complement — not replace — existing screening modalities. Adds a non-invasive, low-burden option to the clinical toolkit.
Actionable reports
Reports are structured for clinical decision-making, with clear findings, confidence levels, and recommended follow-up pathways.
Minimal workflow disruption
The entire process — from sample collection to report — is designed to fit within a standard clinical appointment.
Clinical validation program
We are actively conducting clinical validation studies in partnership with leading oncology centers. Inquire about participation.
Interested in partnering or piloting?
We are working with select clinical partners to validate and deploy the Exhale Science platform. If you are a clinician, health system, or research institution, we would like to hear from you.